Suppr超能文献

氯氮平:一种新型抗精神病药物。

Clozapine: a novel antipsychotic.

作者信息

Buch D L

机构信息

Hahnemann University School of Medicine, Philadelphia, Pennsylvania.

出版信息

Am Fam Physician. 1992 Feb;45(2):795-9.

PMID:1739062
Abstract

Clozapine is the first truly new antipsychotic drug introduced in the last 40 years. Compared to traditional neuroleptic agents, clozapine appears to have a stronger effect on most schizophrenic symptoms. Thus, it seems to be more effective than other agents in severely ill, treatment-resistant patients. Clozapine rarely causes extrapyramidal symptoms such as pseudoparkinsonism or akathisia. To date, no confirmed cases of tardive dyskinesia have been attributed to the drug. Despite these advantages, the usefulness of clozapine is limited by its potentially life-threatening side effects, which include agranulocytosis and respiratory depression.

摘要

氯氮平是过去40年来推出的第一种真正意义上的新型抗精神病药物。与传统抗精神病药物相比,氯氮平似乎对大多数精神分裂症症状有更强的疗效。因此,在重症、难治性患者中,它似乎比其他药物更有效。氯氮平很少引起锥体外系症状,如假性帕金森症或静坐不能。迄今为止,尚无确诊的迟发性运动障碍病例归因于该药物。尽管有这些优点,但氯氮平的应用受到其潜在的危及生命的副作用的限制,这些副作用包括粒细胞缺乏症和呼吸抑制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验